Conference call on Interim Report

Invitation to attend XVIVO Perfusion’s conference call regarding the presentation of the Interim report April - June 2018. The presentation will be held in English.

Time: Friday, July 20, 2018 at 2.00 p.m. CET 

Registration can preferably be done in advance under the following link:
http://event.onlineseminarsolutions.com/wcc/r/1789895-1/370D12262D8ADF763D4C323D0DAEA7FB

or shortly before time of the conference starts on:
Sweden dial in number: +46 (0)8 5059 6306

USA dial in number: +1 718 873 9077
International dial in number: +44 (0)203 139 4830
Conference name: XVIVO Interim Report Q2 2018, conference ID: 6338175# 

Participants from XVIVO Perfusion:
Magnus Nilsson, CEO
Christoffer Rosenblad, CFO

The press release for XVIVO Perfusion’s interim report will be released before the conference call.

Before the conference call, slides will be available at the company web page, www.xvivoperfusion.com/corporate/.

July 12, 2018
Gothenburg
XVIVO Perfusion AB (publ)

For further information please contact:

Christoffer Rosenblad, CFO, +46 735 192159, christoffer.rosenblad@xvivoperfusion.com
Magnus Nilsson, CEO, +46 31-788 21 50, e-post: magnus.nilsson@xvivoperfusion 

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

______________________________________________________________________________________________________________________

XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation.
The company is headquartered in Gothenburg, Sweden, and has one office in Lund, Sweden and one office in Denver, the USA. The XVIVO share is listed on Nasdaq Stockholm and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com.
______________________________________________________________________________________________________________________

XVIVO Perfusion AB (publ), Box 53015, SE-400 14 Göteborg. Corporate identity number 556561-0424.
Tel: 46 31 788 21 50. Fax: 46 31 788 21 69.
E-mail: info@xvivoperfusion.com. Website: www.xvivoperfusion.com

Tags:

Subscribe